A therapeutic agent for pathology caused by increased expression of genes dependent on the transcription factor ETS1 or ETS2

摘要

The present invention inhibits the transcriptional function of transcription factor ets1 or ets2 by CDK inhibitors, thereby causing pathological phenomena caused by increased expression of genes dependent on transcription factor ets1 or ets2, such as rheumatoid and cancer cell metastases. In relation to the present invention, therapeutic agents for pathologies caused by increased expression of genes dependent on the transcription factor ets1 or ets2 of the present invention include CDK inhibitors such as Flavopyridol and Olomucin.